HR 4424
118th Congress
House
Armed Forces and National Security
Asia
Cancer
Conflicts and wars
Congressional oversight
Government studies and investigations
Health information and medical records
Medical research
Veterans' medical care
Vietnam
Vietnam Veterans Liver Fluke Cancer Study Act
Everywhere this bill has been
19 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 18, 2024
Received in the Senate.
Sep 17, 2024
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5277)
Sep 17, 2024
DEBATE - The House proceeded with forty minutes of debate on H.R. 4424.
Sep 17, 2024
Considered under suspension of the rules. (consideration: CR H5277-5278)
Sep 17, 2024
Mr. Bost moved to suspend the rules and pass the bill, as amended.
Sep 17, 2024
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5277)
Sep 17, 2024
Motion to reconsider laid on the table Agreed to without objection.
Jul 22, 2024
Reported (Amended) by the Committee on Veterans' Affairs. H. Rept. 118-600.
Jul 22, 2024
Placed on the Union Calendar, Calendar No. 500.
May 1, 2024
Committee Consideration and Mark-up Session Held
May 1, 2024
Ordered to be Reported in the Nature of a Substitute by Voice Vote.
May 1, 2024
Subcommittee on Disability Assistance and Memorial Affairs Discharged
Apr 16, 2024
Forwarded by Subcommittee to Full Committee by Voice Vote.
Apr 16, 2024
Subcommittee Consideration and Mark-up Session Held
Mar 21, 2024
Subcommittee Hearings Held
Oct 24, 2023
Referred to the Subcommittee on Health.
Aug 8, 2023
Referred to the Subcommittee on Disability Assistance and Memorial Affairs.
Jun 30, 2023
Referred to the House Committee on Veterans' Affairs.
Jun 30, 2023
Introduced in House
Plain-English summary
Vietnam Veterans Liver Fluke Cancer Study Act
This bill requires the Department of Veterans Affairs (VA) to conduct an epidemiological study and report on the prevalence of cholangiocarcinoma (bile duct cancer) in veterans who served in the Vietnam theater of operations during the Vietnam era. The study shall identify the rate of incidence of cholangiocarcinoma in such veterans and in U.S. residents.
The bill also requires the VA to track and report on the prevalence of cholangiocarcinoma using the Veterans Affairs Central Cancer Registry.
Additionally, the bill extends certain loan fee rates through November 29, 2031, under the VA's home loan program.
What's happening now
Received in the Senate.
Committees of jurisdiction
3